Sirikalaya Brimson

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Induced Apoptosis

Endoplasmic Reticulum Stress

Top Venues

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets (2023)
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, Sirikalaya Brimson, Tewin Tencomnao, James Michael Brimson
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. CNS drugs (2023)
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, Sirikalaya Brimson, Tewin Tencomnao, James Michael Brimson
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. CNS drugs (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukaemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, Sirikalaya Brimson, Premrutai Thitilertdecha, Tewin Tencomnao
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy. Expert opinion on therapeutic targets 25 (6) (2021)